About Stephen Seiler
Form D filings for Diceros Therapeutics from 2022 to 2024 list Stephen Seiler as president & CEO, director.
Stephen Seiler first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Stephen Seiler in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stephen Seiler works with at each company, as listed on that company's latest Form D.
Diceros Therapeutics, Inc. · Form D/A, Aug 5, 2024
